抗高血压药物和抑郁症之间的因果关系:关于药物点的门德尔式随机化研究
Zixian Yang1, Jinshuai Li2, Peichu Huang1,3
1Department of Neurology, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, Guangdong, China.
Frontiers in endocrinology
|August 26, 2024
概括
β-阻断剂和通道阻断剂可能会增加抑郁症的风险. 这项门德尔随机化研究强调了在处方这些抗高血压药物时考虑遗传因素的重要性.
科学领域:
- 药物基因组学 药物基因组学
- 心血管医学 心血管医学
- 精神病学是一个精神病学.
背景情况:
- 抑郁症是全球重要的健康负担.
- 抗高血压药物和抑郁症之间的联系受到争论.
- 这项研究使用遗传点调查因果关系.
研究的目的:
- 评估抗高血压药物对抑郁风险的影响.
- 为了利用孟德尔的随机化,专注于药物标.
- 评估五种类型的抗高血压药物:ACEI,ARB,CCB,BB和TD.
主要方法:
- 从GWAS数据中收集了与药物标相关的单核酸多态 (SNP).
- 使用SNP作为抗高血压药物的遗传代理.
- 进行了门德尔的随机化分析,以评估对抑郁症的影响.
主要成果:
- 对β-阻断剂 (BBs) 的遗传代理表明与抑郁症风险增加有关 (OR=1.027,p<0.001).
- 通道阻断剂 (CCB) 的遗传代理与更高的抑郁风险有关 (OR=1.030,p=0.006).
- 没有发现ACEI,ARB或TD与抑郁风险的显著关联.
结论:
- β-阻断剂和通道阻断剂可能会增加抑郁症的风险.
- 在处方这些抗高血压药时,应考虑遗传倾向.
- 这种方法有助于预防风险患者的抑郁症.
相关概念视频
Antidepressant Drugs: Overview
394
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
394
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Antihypertensive Drugs: Direct Renin Inhibitors
512
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
512
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
337
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
337


